⌘K

Home/Filings/4/0000899243-21-024532

4//SEC Filing

Aivado Manuel 4

Accession 0000899243-21-024532

CIK 0001420565other

View on SEC.gov Company Profile

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 7:56 PM ET

Size

5.5 KB

Accession

0000899243-21-024532

Insider Transaction Report

Form 4

Period: 2021-06-15

AILERON THERAPEUTICS INCALRN

Director

Transactions

Award
Stock Option (right to buy)
2021-06-15+2,440,000→ 2,440,000 total
Exercise: $1.29Exp: 2031-06-14→ Common Stock (2,440,000 underlying)

Footnotes (1)

[F1]This option was granted on June 15, 2021. The shares underlying the option are scheduled to vest as to 25% of the shares on June 15, 2022 and thereafter in equal monthly installments through June 15, 2025.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

AILERON THERAPEUTICS INC

CIK 0001420565

Entity typeother

Related Parties

1

filerCIK 0001709603

Filing Metadata

Form type: 4
Filed: Jun 16, 8:00 PM ET
Accepted: Jun 17, 7:56 PM ET
Size: 5.5 KB

View on SEC.gov